3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Neoplasms
16
Leukemia, Myeloid, Acute
10
Ovarian Neoplasms
8
Neoplasm Metastasis
7
Lung Neoplasms
7
Lymphoma
6
Hematologic Neoplasms
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Multiple Myeloma
5
Glioblastoma
5
Stomach Neoplasms
4
Leukemia
4
Fatigue
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Pain
3
Myelodysplastic Syndromes
3
Motor Activity
3
Melanoma
3
Fallopian Tube Neoplasms
3
Depression
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Interventions
Counseling
3
Motivational Interviewing
2
College Fraternities and Sororities
2
Transportation
1
Spermine Synthase
1
Risk Factors
1
Risk Assessment
1
Riluzole
1
Price Transparency
1
Precision Medicine
1
Palliative Care
1
Methods
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
House Calls
1
Exercise
1
Ethanol
1
Educational Status
1
Decision Support Techniques
1
Cannabidiol
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Behavior
×
Palliative Care
×
Clear all
NCT04598646
2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA
Completed
30 enrolled